Gisbert J P, Blanco M, Benito L M, Pajares J M
Department of Gastroenterology, Hospital de la Princesa, Universidad Autónoma, Madrid, Spain.
Clin Infect Dis. 2000 Jun;30(6):976-80. doi: 10.1086/313820.
In this study several therapies were administered to 124 H. pylori-positive patients and IgG antibody titers were measured by ELISA at months 0, 2, 3, 6, 12, and 18 months. Serum titers of IgG antibody progressively decreased after H. pylori eradication; at 3 months, the area under the receiver operating characteristic curve for the decrease of IgG antibody titers for confirming H. pylori eradication was 0.99, with 100% sensitivity and 99% specificity (when the cutoff point was set at 3 U/mL). We conclude that a decrease in serum titers of IgG antibody to H. pylori relatively early after completion of therapy (1 month after ranitidine or bismuth therapy is completed and 2.5 months after antibiotic therapy is completed) can be used as a noninvasive, simple, and inexpensive method to confirm H. pylori eradication.
在本研究中,对124例幽门螺杆菌阳性患者实施了多种治疗,并在第0、2、3、6、12和18个月通过酶联免疫吸附测定法(ELISA)测量了IgG抗体滴度。幽门螺杆菌根除后,IgG抗体的血清滴度逐渐下降;在第3个月时,用于确认幽门螺杆菌根除的IgG抗体滴度下降的受试者工作特征曲线下面积为0.99,敏感性为100%,特异性为99%(当临界值设定为3 U/mL时)。我们得出结论,治疗完成后相对早期(雷尼替丁或铋剂治疗完成后1个月,抗生素治疗完成后2.5个月)幽门螺杆菌IgG抗体血清滴度的下降可作为一种无创、简单且廉价的方法来确认幽门螺杆菌的根除。